Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.

Environmental chemicals may affect human health by disrupting endocrine function. Their possible role in the mammary gland and breast tumors is still unknown. Previous studies have demonstrated that vascular endothelial growth factor (VEGF), a key factor in angiogenesis and tumor progression, is an estrogen-regulated gene. We analyzed whether VEGF expression is regulated by different xenoestrogens in several breast cancer cells, MELN (derived from MCF-7) and MELP (derived from MDA-MB-231) and stably expressing estrogen receptor alpha (ERalpha); these cell lines stably express estrogen response element (beta-globin)-luciferase. Genistein, bisphenol A (BPA), 4-(tert-octyl)phenol (OP), dieldrin, and several phthalates, including benzyl butyl phthalate (BBP) and di-ethyl-2-hexyle phthalate (DEHP), were first shown to be estrogenic. These compounds induced a dose-dependent increase of VEGF secretion in MELN and MCF-7 cells; maximal effect was observed at 1-10 microM non-cytotoxic concentrations and was inhibited by the antiestrogen ICI 182 780. VEGF increase was not observed in ERalpha-negative MDA-MB-231 cells. Most substances increased VEGF transcript levels in MELN cells. In contrast, gamma-hexachlorocyclohexane, vinclozolin, and the phthalates (mono-n-butyl ester phthalic acid, di-isononyle phthalate, and di-isodecyle phthalate) were ineffective on both VEGF secretion and estrogenic luciferase induction in these cell lines. Specific kinase inhibitors PD98059, SB203580, or LY294002 suppressed the xenoestrogen-induced VEGF response, suggesting activation of MEK, p38 kinase, and phosphatidylinositol-3-kinase pathways. Our in vitro results show for the first time that genistein and xenoestrogens (BPA, OP, dieldrin, BBP, and DEHP at high concentrations) up-regulate VEGF expression in MELN cells by an ER-dependent mechanism. Since VEGF increases capillary permeability and breast tumor angiogenesis in vivo, the physiological relevance of these findings is discussed.

[1]  T. Colborn,et al.  Environmental estrogens: health implications for humans and wildlife. , 1995, Environmental health perspectives.

[2]  J C Lhuguenot,et al.  Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s). , 2001, Toxicology and applied pharmacology.

[3]  N. Olea,et al.  Xenoestrogens released from lacquer coatings in food cans. , 1995, Environmental health perspectives.

[4]  J. Nicolas,et al.  Reporter cell lines to study the estrogenic effects of xenoestrogens. , 1999, The Science of the total environment.

[5]  B. Madhukar,et al.  Xenobiotics released from fat during fasting produce estrogenic effects in ovariectomized mice. , 1997, Cancer research.

[6]  M. Karkkainen,et al.  Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells , 1999, Molecular and Cellular Endocrinology.

[7]  Linda S Birnbaum,et al.  Cancer and developmental exposure to endocrine disruptors. , 2002, Environmental health perspectives.

[8]  L. Gray,et al.  Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. , 1997, Toxicology and applied pharmacology.

[9]  M. Perrot-Applanat,et al.  A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Y. Meng,et al.  Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.

[11]  F. Faruque,et al.  Breast cancer and environmental risks: where is the link? , 2004, Journal of environmental health.

[12]  C. Watson,et al.  Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells , 2004, Breast Cancer Research.

[13]  Mariana F. Fernández,et al.  Analysis of population characteristics related to the total effective xenoestrogen burden: a biomarker of xenoestrogen exposure in breast cancer. , 2007, European journal of cancer.

[14]  J. Simons,et al.  Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  A. Starek.  Estrogens and organochlorine xenoestrogens and breast cancer risk. , 2003, International journal of occupational medicine and environmental health.

[16]  M. Perrot-Applanat,et al.  VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. , 2005, Experimental cell research.

[17]  M. Mueller,et al.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D Stewart Irvine,et al.  How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? , 2004, BMJ : British Medical Journal.

[19]  Brad Saville,et al.  Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins , 2004, Oncogene.

[20]  S. Safe.  Clinical correlates of environmental endocrine disruptors , 2005, Trends in Endocrinology & Metabolism.

[21]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[22]  P. Balaguer,et al.  Activation of retinoic acid receptor-dependent transcription by organochlorine pesticides. , 2005, Toxicology and applied pharmacology.

[23]  Jean-Pierre Cravedi,et al.  Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit α and β estrogen activities and antiandrogen activity in reporter cell lines , 2002, Molecular and Cellular Endocrinology.

[24]  B Stein,et al.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.

[25]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[26]  C. Dabrosin.  Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle. , 2003, The Journal of clinical endocrinology and metabolism.

[27]  C. Sonnenschein,et al.  In Utero Exposure to Bisphenol A Alters the Development and Tissue Organization of the Mouse Mammary Gland1 , 2001, Biology of reproduction.

[28]  K. Korach,et al.  Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens. , 2002, The Journal of biological chemistry.

[29]  C. Dabrosin,et al.  Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. , 2003, Cancer research.

[30]  Abraham Brouwer,et al.  Effects of Dioxins and Polychlorinated Biphenyls on Thyroid Hormone Status of Pregnant Women and Their Infants , 1994, Pediatric Research.

[31]  Hiroyuki Tsuda,et al.  Possible enhancing effects of atrazine and nonylphenol on 7,12‐dimethylbenz[a]anthracene‐induced mammary tumor development in human c‐Ha‐ras proto‐oncogene transgenic rats , 2004, Cancer science.

[32]  A. Brodie,et al.  Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. , 1996, Endocrinology.

[33]  Jack Gauldie,et al.  Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer , 2003, International journal of cancer.

[34]  R. Sharpe,et al.  Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. , 2003, Human reproduction.

[35]  Carlos Sonnenschein,et al.  An updated review of environmental estrogen and androgen mimics and antagonists , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  Anne Marie Vinggaard,et al.  Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. , 2002, Toxicology and applied pharmacology.

[37]  Ryoiti Kiyama,et al.  Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. , 2004, Environmental health perspectives.

[38]  J. Toppari,et al.  Putative effects of endocrine disrupters on pubertal development in the human. , 2002, Best practice & research. Clinical endocrinology & metabolism.

[39]  Ana M Soto,et al.  Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. , 2007, Endocrinology.

[40]  G. Stancel,et al.  Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. , 2000, Cancer research.

[41]  V. Jordan,et al.  Endocrine pharmacology of antiestrogens as antitumor agents. , 1990, Endocrine reviews.

[42]  I. Kano,et al.  Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. , 2003, Biological & pharmaceutical bulletin.

[43]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.

[44]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[45]  J. Pouysségur,et al.  Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases , 2002, The Journal of Biological Chemistry.

[46]  A D Vethaak,et al.  Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[47]  J. Holme,et al.  Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4'-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7. , 2003, Pharmacology & toxicology.

[48]  P. Grandjean,et al.  Organochlorine exposure and risk of breast cancer , 1998, The Lancet.

[49]  A. Sasco,et al.  Breast Cancer Risk and the Combined Effect of Environmental Estrogens , 2004, Cancer Causes & Control.

[50]  I. Bièche,et al.  Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression. , 2003, Carcinogenesis.

[51]  C. Hopenhayn-Rich,et al.  Regional Assessment of Atrazine Exposure and Incidence of Breast and Ovarian Cancers in Kentucky , 2002, Archives of environmental contamination and toxicology.

[52]  M. Zabik,et al.  Dieldrin storage of obese, normal, and semistarved rats. , 1973, Archives of environmental health.

[53]  Jun Wang,et al.  Prenatal TCDD and predisposition to mammary cancer in the rat. , 1998, Carcinogenesis.

[54]  H. Leffers,et al.  Comparison of Short-Term Estrogenicity Tests for Identification of Hormone-Disrupting Chemicals , 1999, Environmental health perspectives.

[55]  U. Thorgeirsson,et al.  VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms , 2005, Laboratory Investigation.

[56]  K. Nephew,et al.  Effects of the Xenoestrogen Bisphenol a on Expression of Vascular Endothelial Growth Factor (VEGF) in the Rat , 2001, Experimental biology and medicine.

[57]  D. O’Rourke,et al.  Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. , 2000, Cancer research.

[58]  Wissem Mnif,et al.  Estrogens and antiestrogens activate hPXR. , 2007, Toxicology letters.

[59]  G. Stancel,et al.  Progestin regulation of vascular endothelial growth factor in human breast cancer cells. , 1998, Cancer research.

[60]  B. Térouanne,et al.  Effect of organochlorine pesticides on human androgen receptor activation in vitro. , 2004, Toxicology and applied pharmacology.

[61]  J. Nicolas,et al.  Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands. , 2001, Luminescence : the journal of biological and chemical luminescence.

[62]  M. Perrot-Applanat,et al.  Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation , 2004, Angiogenesis.

[63]  S. Milligan,et al.  Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. , 1998, Environmental health perspectives.

[64]  Carlos Sonnenschein,et al.  Endocrine disruptors and reproductive health: The case of bisphenol-A , 2006, Molecular and Cellular Endocrinology.

[65]  H. Michna,et al.  Effects of the environmental estrogens bisphenol A, o,p′-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7 , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[66]  Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.

[67]  C Sonnenschein,et al.  The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. , 1995, Environmental health perspectives.

[68]  Wei Fang Chen,et al.  Diosgenin Induces Hypoxia-Inducible Factor-1 Activation and Angiogenesis through Estrogen Receptor-Related Phosphatidylinositol 3-kinase/Akt and p38 Mitogen-Activated Protein Kinase Pathways in Osteoblasts , 2005, Molecular Pharmacology.

[69]  B. Madhukar,et al.  Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. , 1996, Cancer research.

[70]  J. Milanini,et al.  Transcriptional Regulation of Vascular Endothelial Growth Factor by Estradiol and Tamoxifen in Breast Cancer Cells: A Complex Interplay between Estrogen Receptors α and β , 2002 .

[71]  S. Safe,et al.  Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[72]  P. Apostoli,et al.  Whole body action of xenoestrogens with different chemical structures in estrogen reporter male mice. , 2004, Toxicology.

[73]  A. Sasco.  Epidemiology of breast cancer: an environmental disease? Note , 2001 .

[74]  K. Korach,et al.  Analysis of the Molecular Mechanisms of Human Estrogen Receptors α and β Reveals Differential Specificity in Target Promoter Regulation by Xenoestrogens* , 2002, The Journal of Biological Chemistry.

[75]  Jenny M. Jones,et al.  Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. , 2005, Molecular endocrinology.

[76]  S. Safe,et al.  Organochlorine exposure and risk for breast cancer. , 1997, Progress in clinical and biological research.

[77]  B. Soria,et al.  Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Rose,et al.  Determination of 4-octylphenol and 4-nonylphenol congeners in composite foods , 2003, Food additives and contaminants.

[79]  R. Koos,et al.  Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. , 1993, Endocrinology.

[80]  B. O’Malley,et al.  Steroid receptor family: structure and functions. , 1990, Endocrine reviews.

[81]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[82]  J. Sumpter,et al.  A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. , 1995, Environmental health perspectives.